Merck & Co Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 03:40PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst

Okay. Welcome to the second day of the BofA Healthcare Conference. My name is Geoffrey Meacham. I'm the senior biopharma analyst. We're thrilled today to have Merck with us. and Caroline Litchfield, CFO, is with me on stage. Welcome, Caroline.

Caroline Litchfield - Merck & Co., Inc. - Executive VP & CFO

Thank you. Great to be here.

Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst

Good to see you. So maybe just talk about following the first quarter give us kind of how you see growth over the balance of the year, and then we'll get into some questions on some of the products and BD, et cetera, et cetera.

Caroline Litchfield - Merck & Co., Inc. - Executive VP & CFO

So let me start with -- it's great to be here. It's amazing that 1 year has flown, and I thank all of you for your interest and support of our company and for being here today. As

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot